AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. SymBio Pharmaceuticals Limited
  3. Financials
  4. Net income margin (%)

SymBio Pharmaceuticals Limited【JP:4582】

Market cap
¥7B
P/E ratio
-2x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndNet income margin (%) YoY (%)
Dec 31, 2025-375+139.94%
Dec 31, 2024-156.3+345.06%
Dec 31, 2023-35.1-398.02%
Dec 31, 202211.8-52.13%
Dec 31, 202124.6-117.97%
Dec 31, 2020-136.9-11.21%
Dec 31, 2019-154.2+114.89%
Dec 31, 2018-71.8-37.86%
Dec 31, 2017-115.5+18.23%
Dec 31, 2016-97.7-28.25%
Dec 31, 2015-136.1+138.53%
Dec 31, 2014-57.1-45.52%
Dec 31, 2013-104.8+18.19%
Dec 31, 2012-88.7-20.70%
Dec 31, 2011-111.8

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)